ask="19.12"
ask_size="500"
average_daily_volume="339039"
bid="18.50"
bid_size="1500"
book_value="3.21"
change="+0.04"
change_from_200_day_moving_average="5.61"
change_from_50_day_moving_average="1.08"
change_from_52_week_high="-4.25"
change_From_52_week_low="14.18"
change_in_percent="+0.21%"
close="18.82"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.47"
ex_dividend_date="N/A"
float_shares="7129000"
high="19.00"
high_52_weeks="23.07"
last_trade_date="2/8/2017"
last_trade_price="18.82"
last_trade_size="5764"
last_trade_time="4:00pm"
low="18.61"
low_52_weeks="4.64"
market_capitalization="187.32M"
moving_average_200_day="13.21"
moving_average_50_day="17.74"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="18.99"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+42.50%"
percent_change_from_50_day_moving_average="+6.09%"
percent_change_from_52_week_high="-18.42%"
percent_change_from_52_week_low="+305.60%"
previous_close="18.78"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.85"
price_per_sales="3306.87"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="7.19"
stock_exchange="NGM"
symbol="ZYNE"
volume="397452"
weeks_range_52="4.64 - 23.07"
